Uppsala, Sweden

Christer Nyström

This inventor holds 3 USPTO granted patents and 6 published patent applications and 9 EPO patents. Top assignee: Orexo Ab. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christer Nyström. Retrieved from https://idiyas.com/inventor/christer-nyström

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Uppsala, SE (2010)
  • Stockholm, SE (2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christer Nyström

Introduction

Christer Nyström is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in formulations that address common health issues such as insomnia and excessive gastric acid secretion. With a total of 3 patents to his name, Nyström's work exemplifies the intersection of science and innovation.

Latest Patents

One of Nyström's latest patents focuses on pharmaceutical formulations useful in the treatment of insomnia. This formulation is designed for transmucosal administration and includes a short-acting hypnotic drug. It provides a measurable plasma concentration of the drug within 10 minutes of administration, allowing for sleep on demand. The formulation typically comprises particles of the drug, such as zolpidem or a pharmaceutically acceptable salt, along with a mucoadhesion promoting agent like sodium carboxymethylcellulose. These components are presented on the surface of larger carrier particles.

Another significant patent by Nyström is a gastric acid secretion inhibiting composition. This oral pharmaceutical dosage form includes pharmacologically effective amounts of an acid-susceptible proton pump inhibitor and an H2 receptor antagonist. The formulation is designed to provide a delayed and/or extended release of the proton pump inhibitor, ensuring a rapid onset and long-lasting effect. This invention is particularly useful for treating conditions associated with excessive gastric acid secretion.

Career Highlights

Throughout his career, Christer Nyström has worked with prominent companies in the pharmaceutical industry, including Orexo AB and AbbVie B.V. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Nyström has collaborated with several professionals in his field, including Anders Pettersson and Yvonne Håkansson. These collaborations have likely enriched his work and led to further advancements in pharmaceutical formulations.

Conclusion

Christer Nyström's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through science. His patents reflect a deep understanding of drug formulation and a dedication to addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…